Marita Ziepert
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Staiger A, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G, Hansmann M, Lenze D, Ziepert M, Horn H, Scott D, Barth T, Bernd H, Feller A, Klapper W, Szczepanowski M, Hummel M, Stein H, German High-Grade Lymphoma Study Group. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. J Clin Oncol 2017; 35:2515-2526.
19.05.2017Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
19.05.2017J Clin Oncol 2017; 35:2515-2526
Staiger Annette M, Hartmann Sylvia, Möller Peter, Cogliatti Sergio B., Lenz Georg, Trümper Lorenz, Löffler Markus, Schmitz Norbert, Pfreundschuh Michael, Rosenwald Andreas, Ott German, Hansmann Martin-Leo, Lenze Dido, Ziepert Marita, Horn Heike, Scott David W, Barth Thomas F E, Bernd Heinz-Wolfram, Feller Alfred C, Klapper Wolfram, Szczepanowski Monika, Hummel Michael, Stein Harald, German High-Grade Lymphoma Study Group
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Horn H, Cogliatti S, Pfreundschuh M, Schmitz N, Trümper L, Siebert R, Loeffler M, Rosenwald A, Ott G, Möller P, Schmelter C, Hansmann M, Ziepert M, Becher C, Barth T, Bernd H, Feller A, Klapper W, Hummel M, Stein H, German High-Grade Non-Hodgkin Lymphoma Study Group. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 2013; 121:2253-63.
18.01.2013MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
18.01.2013Blood 2013; 121:2253-63
Horn Heike, Cogliatti Sergio B., Pfreundschuh Michael, Schmitz Norbert, Trümper Lorenz, Siebert Reiner, Loeffler Markus, Rosenwald Andreas, Ott German, Möller Peter, Schmelter Christopher, Hansmann Martin-Leo, Ziepert Marita, Becher Claudia, Barth Thomas F E, Bernd Heinz-Wolfram, Feller Alfred C, Klapper Wolfram, Hummel Michael, Stein Harald, German High-Grade Non-Hodgkin Lymphoma Study Group
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
Ott G, Frank M, Hansmann M, Barth T, Möller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trümper L, Loeffler M, Müller-Hermelink H, Stein H, Ziepert M, Klapper W, Horn H, Szczepanowski M, Bernd H, Thorns C, Feller A, Lenze D, Hummel M, Rosenwald A. Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. Blood 2010; 116:4916-25.
24.08.2010Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
24.08.2010Blood 2010; 116:4916-25
Ott German, Frank Matthias, Hansmann Martin-Leo, Barth Thomas F E, Möller Peter, Cogliatti Sergio B., Pfreundschuh Michael, Schmitz Norbert, Trümper Lorenz, Loeffler Markus, Müller-Hermelink Hans-Konrad, Stein Harald, Ziepert Marita, Klapper Wolfram, Horn Heike, Szczepanowski Monika, Bernd Heinz-Wolfram, Thorns Christoph, Feller Alfred C, Lenze Dido, Hummel Michael, Rosenwald Andreas
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Bernd H, Möller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trümper L, Höller S, Löffler M, Feller A, Barth T, Müller-Hermelink H, Rosenwald A, Ziepert M, Thorns C, Klapper W, Wacker H, Hummel M, Stein H, Hansmann M, Ott G, German High Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials. Haematologica 2009; 94:1569-80.
01.11.2009Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
01.11.2009Haematologica 2009; 94:1569-80
Bernd Heinz-Wolfram, Möller Peter, Cogliatti Sergio B., Pfreundschuh Michael, Schmitz Norbert, Trümper Lorenz, Höller Silvia, Löffler Markus, Feller Alfred C, Barth Thomas F E, Müller-Hermelink Hans-Konrad, Rosenwald Andreas, Ziepert Marita, Thorns Christoph, Klapper Wolfram, Wacker Hans-Heinrich, Hummel Michael, Stein Harald, Hansmann Martin-Leo, Ott German, German High Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)